What Substances Are Tested in a PHMSA Drug Test

PHMSA drug testing aligns with the U.S. Department of Transportation (DOT) drug tests and follows 49 CFR Part 40. The focus is to ensure safety in hazardous materials transportation by detecting certain controlled substances in employees who perform safety-sensitive duties. The substances listed below are the ones that PHMSA-regulated employers screen for, using a two-step testing process: initial screening and a confirmatory test. This article explains each substance, how testing works, and what results mean for workers and employers.

What Substances Are Included In The PHMSA Drug Test

PHMSA relies on the DOT five-substance group commonly included in workplace drug testing. Each category targets a specific class of drugs that can impair judgment, reaction time, and accuracy in safety-critical roles.

  • Marijuana (Cannabinoids): Includes tetrahydrocannabinol (THC), the psychoactive component of cannabis. Positive results can occur even after medical cannabis use, depending on state law and employer policy.
  • Cocaine: Detects cocaine and its primary metabolite benzoylecgonine. Cocaine impairment affects decision-making and motor skills.
  • Opiates: Encompasses morphine and codeine, with some programs testing for a broader range of natural and synthetic opioids. Prescription use must be controlled and documented to avoid non-compliance.
  • Amphetamines: Covers amphetamine and methamphetamine. This category also captures related stimulants that can influence alertness and coordination.
  • Phencyclidine (PCP): A dissociative drug that impairs perception and judgment, particularly dangerous in safety-sensitive roles.

What Substances Are Not Included In PHMSA Drug Tests

PHMSA’s program does not screen for all drugs. Substances outside the DOT five are not part of the standard DOT drug test panel, though some employers may impose additional testing for specific roles. Examples of substances not typically included in the standard panel are benzodiazepines, barbiturates, and synthetic cannabinoids unless a company has added them to its policy.

✓
Quick, confidential phone check
Tell us the basics and we’ll point you to the right next step. No long forms.
Confidential • Fast • Helpful guidance

Testing Procedure And Specimens

PHMSA drug testing uses a two-step process to ensure accuracy and reduce false results. The initial screen is performed with an immunoassay test, and any positive result is sent for a confirmatory gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS) test.

  • Specimen Type: Urine is the standard specimen for DOT drug testing, though there are provisions for medical exceptions and alternative samples in specific circumstances.
  • Detection Windows: The window lengths vary by substance, frequency of use, and individual metabolism. For example, chronic cannabis use can extend detection beyond a few days, while cocaine, opiates, amphetamines, and PCP typically clear faster in occasional users.
  • Result Codes: DOT-certified laboratories use standardized result codes. A positive result requires confirmation; a substituted or adulterated specimen is treated as a refusal to test and is penalized under the program.

Interpreting Results And Compliance Implications

A confirmed positive result for any of the five substances triggers standard policy actions, which may include removal from safety-sensitive duties, referral to a treatment program, and subsequent return-to-duty testing after regulatory guidelines are met. Employers must preserve confidentiality and adhere to the Family Medical Leave Act (FMLA) and other privacy protections where applicable. CDL or safety-sensitive employees face additional steps before returning to work after a positive test.

Medical Exceptions, Prescriptions, And Documentation

Prescription medications can lead to positive test results if they contain substances in the DOT panel. It is essential for employees to disclose prescribed medications to their supervisor or the medical review officer (MRO) and provide documentation such as a valid prescription. An MRO reviews medical information to determine if a legitimate prescription accounts for the result or if an alternative explanation exists. Employers should maintain a clear policy outlining how to handle prescriptions, medical disclosures, and possible accommodations where safe and lawful.

Recent Updates And Practical Considerations

PHMSA adheres to DOT guidelines, which can periodically update the interpretation and handling of certain substances in response to evolving state laws and federal regulations. Employers should stay informed about changes to the DOT drug-testing program, including the nuances of marijuana legality and testing outcomes. Workers should understand their rights and responsibilities, particularly around reporting prescription medications and understanding the impact of a positive result on employment status and safety responsibilities.

Key Takeaways

  • PHMSA Drug Tests follow the DOT five-substance panel: marijuana, cocaine, opiates, amphetamines, and PCP.
  • Urine testing with a two-step process (screen and confirm) ensures accuracy and regulatory compliance.
  • Prescriptions must be disclosed with proper documentation to avoid misclassification of results.
  • Compliance with PHMSA/DOT rules affects safety-sensitive employment status and return-to-duty processes after a positive result.

Similar Posts